Me ka poʻe e lilo i ka ʻike hou aʻe i nā pono o Oleoylethanolamide (OEA), ke koi no Oleoylethanolamide (OEA) ua māhuahua nui nā mea hoʻohui i ka mākeke. Ua alakaʻi kēia i nā ʻoihana hana e hakakā nei me kekahi i kekahi e hana i nā mea hoʻopihapiha kiʻekiʻe kiʻekiʻe e kiʻi i ka mahele i ka mākeke. Inā ʻoe he mea hana hoʻopihapiha olakino e hoʻolālā nei e hele i loko o ka mākeke hoʻopili ʻo Oleoylethanolamide (OEA), pono ʻoe e hōʻoia e kiʻi ana ʻoe i ka pauka Oleoylethanolamide (OEA) kiʻekiʻe loa. ʻO ka Sourcing mea waiwai maikaʻi ka hana mua i ka hōʻoia ʻana i ka kūleʻa o kēlā me kēia ʻoihana. ʻO Cofttek he ʻoihana Oleoylethanolamide (OEA) mea kūʻai aku nāna e kūʻai aku iā ʻoe i nā huahana pono loa i kēia mākeke ma mua o 10 mau makahiki.

NPP

He aha ka Oleoylethanolamide (OEA)?

Hana ʻia ʻo Oleoylethanolamide i ʻekolu mau huaʻōlelo: oleoyl, ethanol, a me amide. No ko mākou maʻalahi, kuhikuhi mākou iā OEA i ka pōkole. ʻIke ʻia ia me ka oleothanolamine.
He lipid ethanolamide kūlohelohe ia e hana ma ke ʻano he regulator e pili ana i ka hana hānai a me ke kaumaha o ke kino i nā ʻano vertebrates āpau. He metabolite ia o ka oleic acid i hoʻokumu ʻia i loko o ka ʻōpū liʻiliʻi o ke kino o ke kanaka. Hoʻopili ʻia ia i ka PPAR Alpha receptor i kōkua i ka mālama ʻana i nā kumu ʻehā: pōloli, momona o ke kino, cholesterol, a me ke kaupaona. ʻO PPAR Alpha ka manaʻo ʻo Peroxism Proliferator-Activated Receptor Alpha.

Nā hoʻohana o Oleoylethanolamide (OEA)

Hoʻohana ʻia nā hoʻohana o OEA i kahi ʻano rautaki. ʻO ka mea mua, hoʻonui ia i ka hakahaka i ka manawa ma waena o hoʻokahi pāʻina i ka pāʻina aʻe. ʻO ka lua, kōkua ia i ka hōʻemi ʻana i nā fluctuations circadian. ʻO ke kolu, kaohi ʻia e nā meaola i loaʻa.

Ua ʻike ʻia nā hopena hana o OEA a me nā mea e pōmaikaʻi ana he kanalima mau makahiki i hala. ʻAʻole kahi noiʻi e like me ka noiʻi e pili ana iā OEA ma mua o ka makahiki 2001. ʻO nā mea noiʻi mai Sepania i hoʻomaka e hoʻopaʻa e pili ana i ka OEA, i hoʻāʻo ʻia ma nā ʻiole e ʻike i nā hopena. Ua ʻōlelo ʻia ua hoʻopaʻa ʻia ʻaʻohe hopena maikaʻi ʻole o ka OEA i ka lolo akā hiki ke hoʻololi i nā ʻano ʻai a loaʻa ka hopena i ka lawena pōloli.
ʻO C2OH39NO2 ka haʻilula mole. ʻO ka helu CAS kū hoʻokahi ʻo 111-58-0. ʻO ka OEA kahi hui pū ʻia o ka oleic acid a me ka etanolamine. I ke alo o ka momona momona e waiho nei ma ka ʻaoʻao luna o ka ʻōpū liʻiliʻi i loko o kā mākou kino kahi kahi e hana nui ʻia ai ka synthesity o kēia mau ʻelua. Ua like like ʻo OEA a like pū me endocannabinoid anandamide akā ʻoi aku ka maikaʻi.

Ka mahele lāʻau o oleoylethanolamide (oea)

Nā hana o OEA hiki ke lawe ʻia i nā ala ʻelua e pili ana i ka ʻōlelo aʻoaʻo a ke kauka:

Ua lawe ʻo OEA me ka ʻole o nā mea kōkua hoʻoliʻiliʻi kaumaha

Inā lawe ʻia ka capsule OEA me ka ʻole o ka hoʻemi hoʻemi hoʻoliʻiliʻi a laila hiki iā ʻoe ke lawe i ka 1 OEA capsule o 200mg.

Ua lawe ʻo OEA me kekahi kumukanawai hoʻemi hoʻemi

Inā lawe ʻia ka capsule OEA me kahi mea hoʻoliʻiliʻi hoʻoliʻiliʻi kaumaha a laila hiki iā ʻoe ke lawe i ka 1 OEA capsule o 100 mg a 150 mg.

Pono e lawe kekahi i ka capsule OEA kanakolu mau minuke ma mua o ka ʻai ʻana. Mālama kēia iā ʻoe i ka māʻona ʻoiai ke ʻai nei ʻoe a ma laila e hoʻopau ai ʻoe i ka nui o nā meaʻai.

Eia kekahi, hiki iā ʻoe ke hoʻonui a hoʻēmi paha i ka pae o kāu i nā lā o OEA e pili ana i ke kaupaona o kou kino. Kuhi, lawe ke kanaka e kaupaona ana he 150 lb i ka omole OEA o 100mg. Akā inā he 250 paona ke kaupaona o kekahi kanaka, hiki iā ia ke lawe i ka pahu OEA o 180 mg.

Kūʻai i ka pauka Oleoylethanolamide (OEA) i ka nui

Hiki iā ʻoe ke hoʻonohonoho i kahi kauoha pūnaewele no ke kūʻai nui ʻana o ka pauka a i ʻole hiki ke kūʻai mai i nā hale kūʻai kūloko. Maʻalahi ka mālama ʻana i ka pahu o OEA kaola. Pono ʻoe e mālama iā ia i ka mahana o ka lumi. Akā, ʻaʻole pono ia e launa me ka pulu a i ʻole nā ​​kukuna lā pololei. No laila, pono ʻoe e hoʻopaʻa paʻa iā ia i kahi anuanu a maloʻo.

KA KULA KULA

Hiki i nā hoʻohana o OEA ke kōkua iā ʻoe ma nā ʻano like ʻole! No kēia kumu, paipai maikaʻi ʻia i nā mea āpau no ka mea ʻaʻohe ona hopena ʻaoʻao. Hiki iā ia ke hoʻoulu i kahi nohona olakino i loko o kou ʻohana e ulu ana a pau a ʻlohilohi i ke ʻano, kaila, a me ka hilinaʻi a me ka hilinaʻi. ʻO ka mālama ʻana a me ka mālama ʻana i kou kino i ke ʻano, keu hoʻi no ka poʻe momona iki, ʻaʻole wale ia e hoʻohauʻoli iā ʻoe akā e hoʻohauʻoli pū kekahi iā ʻoe.

E kōkua pū ʻo OEA iā ʻoe e hoʻokuʻu i ke koʻikoʻi noʻonoʻo e kōkua ana iā ʻoe e hana i kahi manaʻo maikaʻi i ka manaʻo o haʻi. No laila, ma kahi o ka huhū a me ka hauʻoli ʻole, ua hiki i ka manawa kiʻekiʻe loa e hana i kahi hana a hoʻomaka e hoʻohana i ka OEA a e kahaha loa ʻoe i ka ʻike ʻana i nā mana hoʻokalakupua a ʻike ʻoe i ka hoʻōla a me ka luhi.

Ka hana a Oleoylethanolamide (oea)

ʻO OEA a i ʻole Oleoylethanolamide kahi lāʻau e kōkua iā ʻoe e hoʻoponopono i ke kaupaona, nā ʻano ʻai, a me ka cholesterol. He metabolite maoli ia. Hoʻoponopono ia i ka momona o kou kino ma ka hoʻonui ʻana i ka metabolism o ka momona i loaʻa i kou kino. Hana ia i kahi ala hoihoi loa.

E like a ke lawe ʻoe i ka meaʻai, e hoʻouna kēia lāʻau i hōʻailona i kou lolo e noi ana iā ʻoe e haʻalele i ka ʻai ʻana a i ʻole lawe i nā meaʻai hou aʻe e like me ka lawe ʻana o kou kino i ka meaʻai a pono ʻole. Ma laila, e hoʻomaka ʻoe i ka manaʻo ua māʻona a no laila ke hooki nei ʻoe i ka ʻai ʻana. No laila, hoʻomau ʻoe i ka lawe ʻana i ka nui o nā meaʻai i kēlā me kēia manawa maʻamau. No laila, i ka holo lōʻihi, hiki iā ʻoe ke hōʻemi i ke kaumaha i kahi nui.

Nā pono o Oleoylethanolamide (OEA)

1.Hōʻemi i ka pae o ghrelin

ʻO Ghrelin kahi homone i loaʻa i ko mākou kino e hoʻonāukiuki i ko mākou makemake. Ua ʻike ʻia he kōkua ʻo OEA e hōʻemi i kēia pae hormonone i loko o kā mākou kino inā lawelawe ʻia kēia OEA.

2.Hoʻoemi i ka momona o ke kino i ka nui hoʻonui

ʻIke ʻia ka maikaʻi o kēia ʻoki ʻana i ka hōʻemi ʻana i ka momona o ke kino a ʻo ia hoʻi ma kahi hoʻonui hoʻonui. Hoʻonui ia i nā hopena metabolism o ka mitochondria. Hiki iā ia keʻoki i ka lawe ʻana o ka meaʻai i kahi ʻano kūpono a hoʻonui pū i ka pae ikehu o kou kino.

3.Mālama i ka peptide yy pae haʻahaʻa

ʻO Peptide YY kahi hormone e hoʻonāukiuki i ko mākou makemake. ʻO nā inikua OEA inā lawe ʻia e kōkua ia e hōʻemi a mālama i ka pae o ka pae hormonone Peptide YY haʻahaʻa loa.

4. Kōkua e kaohi i ka makemake

ʻO ka lawe ʻana i ka OEA injection e kōkua ia e kaohi i ka makemake ma ka hoʻopōkole ʻana i kahi o ka momona i loko o kā mākou kino. Hoʻonui ia i ke ahi o ka momona i hōʻiliʻili ʻia i loko o kā mākou kino. As a ke lawe ʻoe i ka meaʻai, hoʻomaka ka hana o OEA. Hāpai ia i kāna pae hana a ma ka manawa like e hoʻēmi ai i kāu pae makemake ma o ka hoʻouna ʻana i nā hōʻailona i ka lolo a hoʻomaopopo e māʻona nui ʻoe a ʻaʻole ʻoe e koi hou i kahi meaʻai e ʻai ai.

5. ʻAʻohe hopena ʻaoʻao

Ma hope o ka loiloi ʻana i ka OEA, ua manaʻo ʻia ʻaʻole i kū kekahi i kekahi hopena ʻē aʻe ma hope o ka lawelawe ʻana i loko o ke kino. ʻO ka OEA kahi waikawa oleic i lawe ʻia ma ke ʻāpana o kāu papaʻai olakino a momona.

6. Nā hopena maikaʻi i ka hopohopo

Hoʻopili maikaʻi ʻo OEA i ka hopohopo. ʻO ka lawe ʻana o OEA e kōkua i ka mālama ʻana i kou noʻonoʻo mai ka hopohopo a kōkua i ka mālama ʻana i nā maʻi kūpilikiʻi.

7. Hoʻonui i ka hdl i ke kino

Aia ʻelua ʻano kolesterol i loko o ko mākou kino. ʻO lākou- LDL Cholesterol a me HDL Cholesterol. ʻO ka LDL ka kolamu maikaʻi ʻole a ʻo ka HDL ka kolesterol maikaʻi. Kōkua ka lawe ʻana i ka OEA e hōʻemi i ka Cholesterol LDL a hoʻonui i ka HDL Cholesterol.

8. Nā kōkua i ke kūkulu kino

ʻO ke kūkulu ʻana i kou kino i ke ʻano a me ke ʻano kūpono a i ka like kaulike kekahi o nā ʻano hou loa i ko kēia ao. ʻOi aku i ka ʻoihana a me nā ʻoihana leʻaleʻa i ke kino e koi nui ʻia. Hoʻokomo pū ʻia ka ʻai o OEA i ke kūkulu ʻana i ke kino no ka mea e hoʻohaʻahaʻa i ka momona i kou kino.

ʻO ka mea lako mai o Oleoylethanolamide (OEA)

Hiki i kekahi ke kūʻai aku i ka lāʻau OEA mai kahi hale kūʻai lāʻau lapaʻau kaulana a mākaukau hoʻi e kū kokoke ana i kou wahi noho a i ʻole hiki ke kūʻai aku iā ia ma ke kauoha ʻana ma ka pūnaewele. Akā e makaʻala nui kekahi i kēia ʻano no ka mea ʻaʻole ʻoiaʻiʻo nā mea hoʻolako i kēia lāʻau.

No laila, nānā mau i ka kaulana a me ka makaukau o ka nā hale kūʻai lāʻau lapaʻau pūnaewele a no kēlā mea, aʻoaʻo mau ʻia e hele i loko o nā kikoʻī o nā loiloi o nā mea kūʻai aku ʻike. E nānā pono e pili ana i ka ʻūpā o ka huahana e like me ka sila sila pono ʻole ʻole e hōʻalo i kekahi ʻano o ka hoʻohaumia ʻana i hiki ke hopena i nā pilikia weliweli i mua o ke olakino.

ʻO Oleoylethanolamide (oea) i ke ʻano o ka pauka

ʻAʻole loaʻa ka OEA i kona ʻano kumu i ke ʻano o nā papa a i ʻole nā ​​capsule. Eia nō naʻe, hiki iā ʻoe kūʻai i ka pauka OEA i ka nuii ka mākeke inā koi ʻia. Hoʻokomo ʻia kēia pepa pauka i ka pau huahana ma ka hoʻoponopono ʻana iā 15% OEA a i ʻole 50% OEA waikawa ʻakika. Mālama ʻia ka blueprint o Cima OEA ma waena o 90% a 95% ma waena o ka poʻe kūʻai mai o ʻEulopa a me ʻAmelika Hui Pū ʻIa.

Oleoylethanolamide (OEA) infogram 1
Oleoylethanolamide (OEA) infogram 2
Oleoylethanolamide (OEA) infogram 3
Paukū ma:

ʻO Kauka Zeng

Co-hoʻokumu, alakaʻi alakaʻi o ka ʻoihana o ka ʻoihana; Loaʻa ʻo PhD mai ke Kulanui ʻo Fudan i ka kemika kemika. Ma mua o ʻeiwa mau makahiki o ka ʻike i ke kemika kemika a me ka synthesis hoʻolālā lāʻau; ʻaneʻane 10 mau pepa noiʻi i paʻi ʻia i loko o nā puke pai mana, me ʻoi aku o ʻelima mau Sila Nui Kina.

E hoʻomaopopo '

(1).Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J. Ka hopena o rimonabant, kahi mea hoʻokipa receptor cannabinoid-1, ma ke kaupaona a me nā mea maʻi maʻi cardiometabolic i nā mea maʻi keu a me nā mea momona paha: RIO-ʻAmelika Hema: kahi hoʻokolokolo hoʻokolohua kaulike ʻole ʻia. ʻO ka puke pai o ka ʻAmelika Hui Pū ʻIa ʻAmelika. 2006; 295 (7): 761-775.

(2).Giuseppe Astarita; Bryan C. Rourke; Johnnie B. Andersen; Jin Fu; Janet H. Kim; Albert F. Bennett; James W. Hicks & Daniele Piomelli (2005-12-22). "Hoʻonui ka hoʻonui o ka hoʻoliʻiliʻi oleoylethanolamine i ka ʻōpū liʻiliʻi o ka python Burmese (Python molurus)". ʻO Am J Physiol Regul Integr Comp Physiol. 290 (5): R1407 – R1412.

(3). ʻO Sarro-Ramirez A, ʻo Sanchez-Lopez D, ʻo Tejeda-Padron A, ʻo Frias C, ʻo Zaldivar-Rae J, ʻo Murillo-Rodriguez E. Nā molekiola a me ka makemake: ka hihia o oleoylethanolamide. Nā Agena Pūnaewele Nervous Waena ma ke Kelekema Medicinal. 2013; 13 (1): 88-91.

(4).Huakaʻi e mākaʻikaʻi egt

(5).Anandamide vs CBD: ʻo wai ka mea ʻoi aku ka maikaʻi no kou olakino? ʻO nā mea āpau āu e ʻike ai e pili ana iā lākou!

(6).ʻO nā mea āpau e pono ai ʻoe e ʻike e pili ana i ka ribotide ribotide nikotinamide.

(7).ʻO nā mea kōkua Magnesium l-threonate: nā pono, nā hana, a me nā hopena ʻaoʻao.

(8).Palmitoylethanolamide (pea): nā pono, nā huahana, nā hoʻohana, nā mea hoʻohui.

(9).ʻO nā pono olakino 6 kiʻekiʻe loa o resveratrol supplement.

(10).ʻO nā pono kiʻekiʻe he 5 o ka lawe ʻana i ka phosphatidylserine (ps).

(11).ʻO 5 keu pono o ka lawe ʻana i ka quyrone pyrroloquinoline (pqq).

(12).ʻO ka waihona nootropic ʻoi loa o ka alpha gpc.

(13).ʻO ke kumukānāwai anti-ʻelemakule maikaʻi loa o nicotinamide mononucleotide (nmn).